Overview VitaDAO is a commun…to and Paul Kohlhaas (https://web.archive.org/web/20260414073639/https://www.vitadao.com/images/vita-la…rated and 3 companies founded.

External links - VitaDAO – o…DAO whitepaper (PDF) (https://web.archive.org/web/20260414073639/https://www.vitadao.com/images/vita-labs/VitaDAO_Whitepaper.pdf) – archived copy of 14 April 2026; vitadao.com stopped serving the file, and its old address answered 404 on 25 September 2026 - VitaDAO governance forum …404 (checked 5 September 2026)

Type DeSci DAO – longevity res…most recent created 9 Sep 2025 (re-queried 15 Sep 2026) Governance forum gov.vitada… most recent post 4 April 2026, unchanged on 15 September 2026 Legal steward Vitality Now, …https://www.vitadao.com/blog) , still the newest post on 15 September 2026; no binding Snapshot ballot s….com (https://www.vitadao.com)

How Caper approaches this The…nt can make – member or not – reimbursed out of the caper's own treasury so that whoever performs it is not out of pocket for doing itand whoever makes it pays that transaction's network fee. Until the redeploy of 11 September 2026 the caper's own treasury reimbursed the caller; a pen-test found the reimbursement could not be limited to the settlement call itself, so it was removed outright (/wiki/governance/execution) . A proposal therefore either …able by a lapsed hosting bill.

How Caper approaches this The…ch locks the caper's trailing seven-day average token price as a baseline and opens a forty-eight-hourthe market window. The payout goes throu…able by a lapsed hosting bill.

External links - VitaDAO – official website (https://www.vitadao.com) - VitaDAO on Snapshot (vote.vitadao.eth) (https://snapshot.box/#/s:vote.vitadao.eth) – the live vote record, 129 proposals - VitaDAO whitepaper (PDF) (https://www.vitadao.com/images/vita-labs/VitaDAO_Whitepaper.pdf) - VitaDAO governance forum (https://gov.vitadao.com/) – live again on 22 August 2026 after the outage this page recorded on 8 August ( category index (https://gov.vitadao.com/categories) ) - VitaDAO Governance constitution (https://gov.vitadao.com/t/vitadao-governance/787) – the escalation ladder and proposal types - VDP-160 – Vitality Now Association setup (https://gov.vitadao.com/t/vdp-160-vitality-now-association-setup-the-new-legal-steward-for-vitadao/1753) - VDP-161 – BIO token airdrop to the VitaDAO community (https://gov.vitadao.com/t/vdp-161-bio-token-airdrop-to-vitadao-community/1755) - VDP-164 – $500K VITARNA loan, with the senior-review digest (https://gov.vitadao.com/t/vdp-164-vitadao-funding-proposal-500k-loan-to-advance-vitarna-through-non-glp-toxicology-toward-2026-ind-submission/2052) - VitaDAO on X (https://x.com/vitadao)

External links - VitaDAO – official website (https://www.vitadao.com) - VitaDAO on Snapshot (vote.vitadao.eth) (https://snapshot.box/#/s:vote.vitadao.eth) – the live vote record, 129 proposals - VitaDAO whitepaper (PDF) (https://www.vitadao.com/images/vita-labs/VitaDAO_Whitepaper.pdf) - VitaDAO governance forum (https://gov.vitadao.com/) – live again on 22 August 2026 after the outage this page recorded on 8 August ( category index (https://gov.vitadao.com/categories) ) - VitaDAO Governance constitution (https://gov.vitadao.com/t/vitadao-governance/787) – the escalation ladder and proposal types - VDP-160 – Vitality Now Association setup (https://gov.vitadao.com/t/vdp-160-vitality-now-association-setup-the-new-legal-steward-for-vitadao/1753) - VDP-161 – BIO token airdrop to the VitaDAO community (https://gov.vitadao.com/t/vdp-161-bio-token-airdrop-to-vitadao-community/1755) - VDP-164 – $500K VITARNA loan, with the senior-review digest (https://gov.vitadao.com/t/vdp-164-vitadao-funding-proposal-500k-loan-to-advance-vitarna-through-non-glp-toxicology-toward-2026-ind-submission/2052) - VitaDAO on X (@vita_dao) (https://x.com/vita_dao) – the handle x.com/vitadao that vitadao.com (https://www.vitadao.com) 's own footer links is a 404 (checked 5 September 2026)

How Caper approaches this The…A caper settles that proposal without a ballot. Nothing is ranked and nothing is tallied: the contractin two phases. Holders first rank the proposal's options on a single ballot, and a Borda fold picks a winner that must clear a supermajority of 1.5 / option_count of the weight actually cast. A pass executes nothing on its own: it earns a trigger, which locks the caper's trailing seven-day average token price at creation,s a baseline and opens a forty-eight-hour window, and passes the proposal if the live curve. The payout goes through only if the window's own time-weighted price icloses at or above that baseline when it is settled. H. The ballot legislates and the market ratifies – holding is consent, and sustained selling is the objection – see…t, it stranded it. On a caper there is no vote to callboth phase transitions – the tally once voting closes, and the resolution once the window does – are permissionless calls on a clock, so there is no vote left for anyone to schedule and nobody whose job it is to callschedule one. The window runs on the c…able by a lapsed hosting bill.

How Caper approaches this The…ry itself, and members hold a participation-weighted claim (/wiki/dao-governance/concepts/membership/rage-quit-and-exit-rights) redeemable claim on it. Research spending is a…(/wiki/governance/proposals) that movesmoving a chosen currency and amount …treasury-management) to a lab once members vote it through (/wiki/governance/voting) . Voting weight is stake weighted by participation rather than raw token balance, so the people funding the science keep governance coupled to their exposure – and there is no separate equity vehicle to stand up to keep the token's price from wandering off from the value being built. There is no separate equity vehicle to stand up to keep the token's price from wandering away from the value being built. A caper settles that proposal without a ballot. Nothing is ranked and nothing is tallied: the contract locks the caper's seven-day average token price at creation, opens a forty-eight-hour window, and passes the proposal if the live curve price is at or above that baseline when it is settled. Holding is consent and selling is the objection – see proposals (/wiki/governance/proposals) and voting (/wiki/governance/voting) . Caper has no view on which …nior review supplies. What it does changes is where a proposal can stall: every proposal a caper's members raise runs to a decision on-ledger, so a funding request. VDP-164 cleared its review with a low score and then never reached the Snapshot vote its own constitution requires: a low score did not reject it, it stranded it. On a caper there is no vote to call and nobody whose job it is to call one. The window runs on the clock, and settlement is a permissionless call any account can make – member or not – reimbursed out of the caper's own treasury so that whoever performs it is not out of pocket for doing it. A proposal therefore either passes or fails on the record rather than; it cannot lapsinge between a review and a vote that is never called. ballot nobody schedules. There is also no size threshol…which a spend skips the record: a. A caper's treasury pays out on …d proposal, and the proposal, each ranked ballot cast against it, and its execution are all stateits settlement – the baseline, the price it settled at and the verdict, all three written to the caper's own state and emitted as and events on the caper's own component – and its execution are all on-ledger. The one other way value leav…sury is a member taking their exit (/wiki/dao-governance/concepts/membership/rage-quit-and-exit-rights) , and that too is a ledger eve…able by a lapsed hosting bill.

Type DeSci DAO – longevity res… 9 Sep 2025 Governance forum gov.vitadao.com – offline; the hostname stopped resolving during 2026 and no replacement is named. Archived copy (https://web.archive.org/web/20260421071625/https://gov.vitadao.com/) (https://gov.vitadao.com/) , a hosted Discourse instance. Unreachable when this page was written on 8 August 2026; resolving and serving the same threads again on 22 August 2026, most recent post 4 April 2026 Legal steward Vitality Now, … (Verein) – VDP-160 (https://web.archive.org/web/20250114000031/https://gov.vitadao.com/t/vdp-160-vita…i Srinivasan Chain Ethereum Status 🟢 Active – longevity newsletter published 14 August 2026 (https://www.vitadao.com/blog) ; no binding Snapshot ballot since 9 September 2025 Website vitadao.com (https://www.vitadao.com)

Overview VitaDAO is a commun…nding role. VDP-161 (https://web.archive.org/web/20250114004345/https://gov.vitadao.com/t/vdp-161-bio-…rated and 3 companies founded.

Governance and the VITA token …ess, shielded format (https://web.archive.org/web/20241116133836/https://gov.vitadao.com/t/how-to-vote-…VitaDAO constitution (https://web.archive.org/web/20260519191733/https://gov.vitadao.com/t/vitadao-gove…VDP-163 FOXO3 oligos (https://web.archive.org/web/20250911080521/https://gov.vitadao.com/t/vdp-163-fund…rs declining to act: with the forum gone and the allowlist unchanged, there ia holder outside those thirteen addresses has no route by which a holder couldto put VDP-164, or anything else…ence rather than a dead venue.

The Vitality Now Association …lishing Vitality Now (https://web.archive.org/web/20250114000031/https://gov.vitadao.com/t/vdp-160-vita… rather than a smart contract.

The senior review, and a propo… example is VDP-164 (https://web.archive.org/web/20260421081428/https://gov.vitadao.com/t/vdp-164-vita…jected in the thread (https://web.archive.org/web/20260421081428/https://gov.vitadao.com/t/vdp-164-vita…/desci-funding) more broadly.

The forum went offline, and took the record with itcame back Every VitaDAO source cited above once pointeds at gov.vitadao.com, the DAO's hosted Discourse forum. As ofOn 8 August 2026 that hostname no longerdid not resolves. It is a CNAME to vitadao.hos…rse.com, and the target carriesd no address record at either C…ic resolver, so a request failsed before it reachesd a server – the signature of a hosted Discourse instance that has been shut down rather than moved. The Internet Archive's last successful capture of the forum is 7 June 2026;. This page was rewritten around that failure, and every forum citation on it was repointed at the Internet Archive. The outage ended. Re-probed on 22 August 2026, the CNAME target answers 184.104.178.43 at both public resolvers and gov.vitadao.com (https://gov.vitadao.com/) serves its topic list again. It is the same instance rather than a fresh one: the VDP-164 thread was last captured on 21 April 2026, and its last post is dated 3 March 2026. Nothing on VitaDAO's own site names a replacement, and the site has not noticed. The homepage's structured-data FAQ still answers "How can researchers apply for VitaDAO funding?" by telling them to submit a proposal through the governance forum at gov.vitadao.com (https://www.vitadao.com) – the DAO's front door is routing new research proposals to an address tha(https://gov.vitadao.com/t/vdp-164-vitadao-funding-proposal-500k-loan-to-advance-vitarna-through-non-glp-toxicology-toward-2026-ind-submission/2052) still ends on the 3 March 2026 reply described above, and the forum's most recent activity anywhere is an introduction posted on 4 April 2026. Every citation on this page has been repointed back at the live thread. The episode stays on the page because what it exposes is a hole in the checking rather than a fault of VitaDAO's. Swapping an archived copy in for a dead URL is the standard repair, and it quietly converts a checkable claim into an unfalsifiable one: a link checker asks whether a URL resolves, web.archive.org always resolves, and nothing ever re-asks whether the original came back. An outage is a state, not an event. This page went on asserting a fortnight-old DNS failure as a settled fact while every automated check it is subject stopped resolving. What passed. The durability argument the outage prompted survived is the half of the stack the DAO does not hostrecovery, because what came back came back at somebody else's discretion. The vote.vitadao.eth Snapsh…ot.box/#/s:vote.vitadao.eth) still returnsed all 129 proposals, their choi…er counts to any keyless query throughout, because a Snapshot vote is a… than a page on a rented one. Every figure in the sections above that comes from a ballot – VDP-160's 862,378 For against 334,534 Abstain, VDP-163's 17 voters – was re-read from that hub this week. Every figure that comes from deliberation is now cited through the Internet Archive, which is a fallback and not a source of record: it holds what a crawler happened to reach, not what the forum held. The pattern generalises past VitaDAO, and it cuts in a direction most DAOs have not pricedThe forum did not, for at least a fortnight. A DAO that keeps its binding…nt durability guarantees, and the reasoning is the half that goes first. It is also the half thatunder VitaDAO's own ladder the hosted half carries the most decisions: under VitaDAO's own ladder everything below $50,000 is s… poll, and none of those leaves an on-chain trace. SoNeither does a proposal that is score… and then never put to a vote. A forum is not an archive, and a DAO that treats it as one is one unpaid invoice away from losing the part of its history that explains the votes.

External links - VitaDAO – o…DAO governance forum (https://web.archive.org/web/20260421071625/https://gov.vitadao.com/) – archived; gov.vitadao.com no longer resolves ( category index, 7 June 2026 (https://web.archive.org/web/20260607104504/gov.vitadao.com/) – live again on 22 August 2026 after the outage this page recorded on 8 August ( category index (https://gov.vitadao.com/catego…ernance constitution (https://web.archive.org/web/20260519191733/https://gov.vitadao.com/t/vitadao-governance/787) – archived; the escalation ladder and pro…ow Association setup (https://web.archive.org/web/20250114000031/https://gov.vitadao.com/t/vdp-160-vita…gal-steward-for-vitadao/1753) – archived - VDP-161 – BIO token airdr…he VitaDAO community (https://web.archive.org/web/20250114004345/https://gov.vitadao.com/t/vdp-161-bio-…op-to-vitadao-community/1755) – archived - VDP-164 – $500K VITARNA l…senior-review digest (https://web.archive.org/web/20260421081428/https://gov.vitadao.com/t/vdp-164-vita…ard-2026-ind-submission/2052) – archived - VitaDAO on X (https://x.com/vitadao)

The senior review, and a propo…mber 2025: a $500,000 loan to VITARNA (/wiki/desci/ecosystem/vitarna) /ArtanBIO, recoverable in a la…/desci-funding) more broadly.

Governance and the VITA token …oposal since 9 September 2025. Who may open a vote is a separate right from who may cast one, and this space grants them to different sets. vote.vitadao.eth (https://snapshot.box/#/s:vote.vitadao.eth) restricts proposal creation to an author allowlist of thirteen addresses – five admins and eight members – which Snapshot documents as restricting proposals “to authors only” (https://docs.snapshot.box/user-guides/spaces/settings) rather than validating a proposer's voting power against a threshold. Every VITA holder can vote; thirteen addresses decide what there is to vote on. That is an ordinary and defensible proposal throttle (/wiki/dao-governance/concepts/voting/proposal-throttles-and-rate-limits) , and it is also why the space's silence cannot be read as members declining to act: with the forum gone and the allowlist unchanged, there is no route by which a holder could put VDP-164, or anything else, to a binding vote. The public-facing description has not followed the practice. VitaDAO's token page still presents VITA in the present tense as the instrument of governance – “By holding VITA, community members can vote on proposals to fund cutting-edge research, influence strategic decisions, and help steward the DAO's treasury” (https://www.vitadao.com/vita-token) – and the site's own “Launch app” destination, app.vitadao.com, is a subscription longevity-AI product rather than a governance surface: its deployed JavaScript bundle, 391 KB read on 18 August 2026, contains no occurrence of governance, proposal, vote, or any Snapshot host. Governance did not move there, and it did not move up to Bio Protocol (/wiki/desci/ecosystem/bio-xyz) either: the documentation index (https://docs.bio.xyz/bio/llms.txt) for the platform that launched the BioDAO cohort lists no governance page at all, and its own vote-escrowed token is described as one that “can eventually confer voting rights in protocol governance (following veBIO gaining sufficient adoption in the system)” (https://docs.bio.xyz/bio/introduction/bio-protocol-v2/staking-and-vebio.md) . The absence is checked against a sibling that shows presence: the same hub returns CryoDAO (https://snapshot.box/#/s:vote.cryodao.eth) 's CRYO-26, closed 31 July 2026, so the reader is looking at one organization's silence rather than a dead venue.

Type DeSci DAO – longevity research Founded June 2021 (first DeSci DAO) Focus Funding early-stage longevity & aging science Token VITA (governance-only, ERC-20) Governance Snapshot (gasless, shielded); weight = VITA held. 129 proposals; most recent created 9 Sep 2025 Legal steward Vitality Now, a Swiss association (Verein) – VDP-160 (https://gov.vitadao.com/t/vdp-160-vitality-now-association-setup-the-new-legal-steward-for-vitadao/1753) , Dec 2024 Ecosystem Bio Protocol (/wiki/desci/ecosystem/bio-xyz) BioDAO IP model IP-NFTs (/wiki/desci/ip-nfts) ( Molecule (/wiki/desci/ecosystem/molecule) tooling); VITA-FAST / VITA-RNA IP tokens Track record 31 projects funded, ~$4.7M deployed, 8 IP tokens generated, 3 companies spun out Notable backers Pfizer Ventures, Shine Capital, Balaji Srinivasan Chain Ethereum Website vitadao.com (https://www.vitadao.com)

Overview VitaDAO is a community-owned collective that funds and advances early-stage longevity science (https://www.vitadao.com) – the first decentralized science (DeSci) (/wiki/desci/what-is-desci) DAO, launched in June 2021 out of a whitepaper by Tyler Golato and Paul Kohlhaas (https://www.vitadao.com/images/vita-labs/VitaDAO_Whitepaper.pdf) of Molecule (/wiki/desci/ecosystem/molecule) , and since grown into the largest organisation in the field. Its aim is to extend human healthspan by pooling community capital to de-risk translational aging research that traditional grant pipelines and venture funds routinely skip. VitaDAO operates as a BioDAO within the Bio Protocol (/wiki/desci/ecosystem/bio-xyz) ecosystem (the network Molecule grew into), and in August 2024 received a 21 million BIO token allocation (https://gov.vitadao.com/t/vdp-161-bio-token-airdrop-to-vitadao-community/1755) from Bio Protocol's bio/acc rewards program in recognition of its founding role – giving it a stake in governing new BioDAO launches and ecosystem incentives. The DAO reports 31 projects funded and roughly $4.7M deployed (https://www.vitadao.com) , split across 3 target-discovery, 18 drug-discovery, 3 preclinical and 3 clinical drug-development projects, with 8 IP tokens generated and 3 companies founded.

Governance and the VITA token $VITA is a governance-only token (https://www.vitadao.com/blog/beginners-guide-to-vita-token) : it confers no dividend and exists to steer the DAO. Voting happens on Snapshot in a gasless, shielded format (https://gov.vitadao.com/t/how-to-vote-on-snapshot/490) – members must hold VITA in an Ethereum wallet, weight scales with the number of tokens held, and results stay hidden until the vote closes so early tallies don't sway later voters. This is textbook token-weighted governance (/wiki/dao-governance/concepts/voting/voting-and-delegation) , and it inherits token-weighted governance's core tension: influence tracks holdings, not contribution. Funding decisions escalate by size. Per the VitaDAO constitution (https://gov.vitadao.com/t/vitadao-governance/787) , a request up to ~$2,500 needs sign-off from two working-group representatives; up to ~$10,000 needs a majority of working-group stewards; up to ~$50,000 goes to a public governance-forum poll; and anything larger requires that poll plus a full Snapshot vote. Day-to-day work runs through specialist working groups (dealflow, tokenomics, awareness, legal and more) staffed by community stewards rather than a single executive team. Turnout at the binding stage is small in absolute terms and lopsided in outcome. The vote.vitadao.eth Snapshot space (https://snapshot.box/#/s:vote.vitadao.eth) has carried 129 proposals; the VDP-163 FOXO3 oligos (https://gov.vitadao.com/t/vdp-163-funding-foxo3-oligos-revised/2033) funding vote closed on 16 September 2025 with 17 voters and 6,618,900 VITA cast entirely For, zero Against and zero Abstain, and the January 2025 BIO airdrop vote drew 37. Those are typical: proposals that reach Snapshot have usually been settled on the forum first, so the on-chain vote ratifies rather than decides – a pattern this wiki covers under voter apathy (/wiki/dao-governance/concepts/analysis/voter-apathy) . That space has recorded no new proposal since 9 September 2025.

The Vitality Now Association In December 2024 VitaDAO's community approved VDP-160, establishing Vitality Now (https://gov.vitadao.com/t/vdp-160-vitality-now-association-setup-the-new-legal-steward-for-vitadao/1753) , a Swiss association (Verein), as the DAO's legal steward. The forum poll closed 10 Agree, 0 Revisions Requested, 0 Disagree. The proposal's framing is explicit about the division of labour: decision power stays with VitaDAO's governance mechanisms, and the association executes those decisions inside Swiss and international law. What the association actually holds is the part worth reading closely. Under VDP-160 it becomes the ultimate beneficial owner of all Pods – the semi-autonomous working units such as the Longevity Pod and the Web3 Pod – and it may own or control holding companies that manage projects and IP portfolios. It signs agreements with research institutions, core and strategic contributors, and service providers; it oversees IP acquisition, licensing and enforcement; and it manages contributors' multisignature wallets and payment streams alongside the Pods. Operational detail is delegated to VitaDAO's Guardians, the body responsible for strategic planning and the DAO's budgetary framework. This is the standard shape of a DAO legal wrapper (/wiki/dao-governance/concepts/membership/dao-legal-structures) : a recognised entity that can hold title, sign contracts, and answer to a regulator, sitting beneath a token vote that cannot do any of those things. The trade is equally standard. Everything the association controls – the IP portfolio, the holding companies, the multisigs, the contributor agreements – is governed on-chain only to the extent the association chooses to follow the vote, and members' recourse if it does not is Swiss association law rather than a smart contract.

IP-NFTs and tokenized research The mechanism that distinguishes VitaDAO from an ordinary grants pool is how it holds what it funds. Rather than handing out cash and walking away, VitaDAO captures the intellectual property of funded projects as IP-NFTs (/wiki/desci/ip-nfts) – on-chain assets, built with Molecule (/wiki/desci/ecosystem/molecule) 's tooling, that the community can govern, license, and commercialise. This turns research IP into a treasury asset the DAO co-owns instead of an outcome it merely sponsors. VitaDAO went a step further with VITA-FAST, the first IP-NFT to be fractionalised into an ERC-20 IP token (https://www.vitadao.com/blog/announcing-the-vita-fast-token-sale-for-viktor-korolchuk-lab) . VITA-FAST represents shared ownership of the "Discovering Novel Autophagy Activators" IP-NFT from the Korolchuk Lab at Newcastle University, and its holders directly govern licensing decisions and experiment priorities for that specific research line. This is tokenomics (/wiki/dao-governance/concepts/treasury/dao-tokenomics) in its most literal DeSci form: a tradeable claim minted directly against a real, governed research asset. The second IP token, VITA-RNA, shows what the pattern looks like once a programme is running for years. Its IP-NFT was tokenized in January 2024 and raised $300,000 for ARTAN Bio, whose lead candidate ARTAN-102 is an engineered suppressor tRNA delivered via AAV9 that reads through premature stop codons to restore full-length protein. The programme's milestones are reported through governance: two lead candidates validated in vitro from an initial screen of 15 oligos in October 2024, a first in vivo study in June 2025 reporting no adverse effects and broad biodistribution including the brain, and GMP process development at Lonza through September 2025. The reporting cadence is the point – an IP token gives holders a reason to be told, and a forum thread to be told in.

Funding, Pfizer, and the token-versus-value question In January 2023 VitaDAO closed a $4.1 million round (https://www.vitadao.com/blog/vitadao-closes-4-1m-fundraising-round-with-pfizer-and-shine-capital) whose backers included Pfizer Ventures, Shine Capital, L1 Digital, Beaker DAO, Spaceship DAO, and individuals such as Balaji Srinivasan and Joe Betts-LaCroix – following Pfizer's initial $500k VITA purchase (https://longevity.technology/news/pfizer-invests-500k-in-vitadao-to-accelerate-longevity-rd/) in September 2022 that made it the first pharmaceutical company to hold a governance token and vote on a DAO proposal. That commercialisation raised a familiar structural problem. In April 2023 VitaDAO members voted to create a for-profit company (https://www.coindesk.com/business/2023/04/05/pfizer-backed-vitadao-votes-on-creating-for-profit-company-to-fund-longevity-research) to carry assets through the capital-intensive stages a community treasury can't underwrite – the same token-versus-equity split AthenaDAO (/wiki/desci/ecosystem/athenadao) later reached for with AthenaBIO. A freely-traded governance token's price drifts away from the value of the underlying science, so the DAO governs and sources while separate legal vehicles hold and commercialise the work. The Vitality Now structure above is where that split ended up: an association at the top, Pods beneath it, and holding companies beneath those.

The senior review, and a proposal that never reached a vote Token voting decides whether a grant is popular. It does not decide whether the science is any good, and VitaDAO layers a scored expert gate in front of the vote to close that gap. The clearest published example is VDP-164 (https://gov.vitadao.com/t/vdp-164-vitadao-funding-proposal-500k-loan-to-advance-vitarna-through-non-glp-toxicology-toward-2026-ind-submission/2052) , proposed on 16 September 2025: a $500,000 loan to VITARNA/ArtanBIO, recoverable in a later fundraise, to fund GMP manufacturing and non-GLP toxicology in non-human primates ahead of a targeted 2026 IND submission. After the forum poll, four reviewers – two biotech entrepreneurs, one biotech VC and one pharma VC, two of them former scientists – scored the proposal out of 5 across seven categories. The published averages were Team Expertise 3.0, Feasibility & Data 2.5, Commercial Potential & Impact 2.0, Novelty & Market Advantage 3.0, IP Defensibility 3.5, Relevance to Longevity 2.5 and Deal Terms 2.5, for an overall conviction score of 2.3 against an average of 3.7 for past funded projects. Asked whether they would endorse it, one reviewer said only after more robust delivery, efficacy and IP data; one said conditionally, contingent on a rigorous preclinical package and a narrowed initial indication; and one said no, on the grounds that the mechanism had not been shown to address a meaningful driver of aging. Publishing the digest then produced a second argument, about the review rather than the science. On 26 February 2026 a member objected in the thread (https://gov.vitadao.com/t/vdp-164-vitadao-funding-proposal-500k-loan-to-advance-vitarna-through-non-glp-toxicology-toward-2026-ind-submission/2052) that only a qualitative summary had been posted, and asked for the reviewer document and the team's written response to be published in full; ARTAN Bio's own chief executive agreed, writing that the community should be able to read the reviews rather than rely on anonymous reviewers whose credentials no one could check. VitaDAO replied on 3 March 2026 that the format matched previous proposals and that it was open to sharing more detail. The governance outcome is the part that generalises. VDP-164 has never appeared on VitaDAO's Snapshot space (https://snapshot.box/#/s:vote.vitadao.eth) , whose most recent proposal was created on 9 September 2025 – a week before VDP-164 was posted. The constitution's escalation ladder says a request this size needs a forum poll and a Snapshot vote; in practice the proposal has spent its entire life at the forum-and-review stage, and the binding vote it would have to clear has not been called. A scored expert gate is a real answer to token voting's competence problem, and this is its characteristic failure mode: a low score does not reject a proposal, it strands one, and the record of what happened next lives in a forum thread rather than in a vote anyone can point to. The same tension runs through DAO procurement and RFPs (/wiki/dao-governance/concepts/analysis/dao-procurement-and-rfps) , where a scoring panel decides who is even eligible to be voted on, and through DeSci funding (/wiki/desci/desci-funding) more broadly.

How Caper approaches this The token-versus-value gap VitaDAO patches with a legal wrapper and a separate commercial vehicle is the seam a caper (/wiki/foundations/what-is-a-caper) is built to close. On Caper, contributed capital flows into the caper's own bonding-curve (/wiki/markets/bonding-curve) treasury rather than into a free-floating governance token whose price detaches from the work – value accrues to the treasury itself, and members hold a participation-weighted claim (/wiki/dao-governance/concepts/membership/rage-quit-and-exit-rights) on it. Research spending is authorised the way any spend is: a PAYOUT proposal (/wiki/governance/proposals) that moves a chosen currency and amount from the treasury (/wiki/dao-governance/concepts/treasury/dao-treasury-management) to a lab once members vote it through (/wiki/governance/voting) . Voting weight is stake weighted by participation rather than raw token balance, so the people funding the science keep governance coupled to their exposure – and there is no separate equity vehicle to stand up to keep the token's price from wandering off from the value being built. Caper has no view on which science is worth funding, and nothing in the protocol substitutes for the expert judgement a senior review supplies. What it does change is where a proposal can stall: every proposal a caper's members raise runs to a decision on-ledger, so a funding request either passes or fails on the record rather than lapsing between a review and a vote that is never called.

External links - VitaDAO – official website (https://www.vitadao.com) - VitaDAO governance forum (https://gov.vitadao.com/) - VitaDAO on Snapshot (vote.vitadao.eth) (https://snapshot.box/#/s:vote.vitadao.eth) - VitaDAO whitepaper (PDF) (https://www.vitadao.com/images/vita-labs/VitaDAO_Whitepaper.pdf) - VDP-160 – Vitality Now Association setup (https://gov.vitadao.com/t/vdp-160-vitality-now-association-setup-the-new-legal-steward-for-vitadao/1753) - VDP-164 – $500K VITARNA loan, with the senior-review digest (https://gov.vitadao.com/t/vdp-164-vitadao-funding-proposal-500k-loan-to-advance-vitarna-through-non-glp-toxicology-toward-2026-ind-submission/2052) - VitaDAO on X (https://x.com/vitadao)

Type DeSci DAO – longevity research Founded June 2021 (first DeSci DAO) Focus Funding early-stage longevity & aging science Token VITA (governance-only, ERC-20) Governance Snapshot (gasless, shielded); weight = VITA held. 129 proposals, 1,150,000 VITA quorum, 7-day voting period; most recent created 9 Sep 2025 Governance forum gov.vitadao.com – offline; the hostname stopped resolving during 2026 and no replacement is named. Archived copy (https://web.archive.org/web/20260421071625/https://gov.vitadao.com/) Legal steward Vitality Now, a Swiss association (Verein) – VDP-160 (https://web.archive.org/web/20250114000031/https://gov.vitadao.com/t/vdp-160-vitality-now-association-setup-the-new-legal-steward-for-vitadao/1753) , Dec 2024 Ecosystem Bio Protocol (/wiki/desci/ecosystem/bio-xyz) BioDAO IP model IP-NFTs (/wiki/desci/ip-nfts) ( Molecule (/wiki/desci/ecosystem/molecule) tooling); VITA-FAST / VITA-RNA IP tokens Track record 31 projects funded, ~$4.7M deployed, 8 IP tokens generated, 3 companies spun out Notable backers Pfizer Ventures, Shine Capital, Balaji Srinivasan Chain Ethereum Website vitadao.com (https://www.vitadao.com)

Overview VitaDAO is a community-owned collective that funds and advances early-stage longevity science (https://www.vitadao.com) – the first decentralized science (DeSci) (/wiki/desci/what-is-desci) DAO, launched in June 2021 out of a whitepaper by Tyler Golato and Paul Kohlhaas (https://www.vitadao.com/images/vita-labs/VitaDAO_Whitepaper.pdf) of Molecule (/wiki/desci/ecosystem/molecule) , and since grown into the largest organisation in the field. Its aim is to extend human healthspan by pooling community capital to de-risk translational aging research that traditional grant pipelines and venture funds routinely skip. VitaDAO operates as a BioDAO within the Bio Protocol (/wiki/desci/ecosystem/bio-xyz) ecosystem (the network Molecule grew into) and holds a 21 million BIO allocation from Bio Protocol's bio/acc rewards programme in recognition of its founding role. VDP-161 (https://web.archive.org/web/20250114004345/https://gov.vitadao.com/t/vdp-161-bio-token-airdrop-to-vitadao-community/1755) put 6.9 million of that allocation back out to the community as an airdrop – 80% (5.52M BIO) to VITA holders and 20% (1.38M BIO) to holders of its IP tokens, tiered by size of holding – and kept the remaining 14.1 million BIO in treasury to fund science. The stake gives VitaDAO a vote in governing new BioDAO launches and ecosystem incentives. The DAO reports 31 projects funded and roughly $4.7M deployed (https://www.vitadao.com) , split across 3 target-discovery, 18 drug-discovery, 3 preclinical and 3 clinical drug-development projects, with 8 IP tokens generated and 3 companies founded.

Governance and the VITA token $VITA is a governance-only token (https://www.vitadao.com/blog/beginners-guide-to-vita-token) : it confers no dividend and exists to steer the DAO. Voting happens on Snapshot in a gasless, shielded format (https://web.archive.org/web/20241116133836/https://gov.vitadao.com/t/how-to-vote-on-snapshot/490) – members must hold VITA in an Ethereum wallet, weight scales with the number of tokens held, and results stay hidden until the vote closes so early tallies don't sway later voters. This is textbook token-weighted governance (/wiki/dao-governance/concepts/voting/voting-and-delegation) , and it inherits token-weighted governance's core tension: influence tracks holdings, not contribution. Funding decisions escalate by size, and the ladder is written down rather than left to convention. Under the VitaDAO constitution (https://web.archive.org/web/20260519191733/https://gov.vitadao.com/t/vitadao-governance/787) , a spend of $10,000 or less needs two working-group stewards to approve; above $10,000 and below $25,000, VitaCore approves by majority vote; from $25,000 to $50,000 the community decides by majority vote on the Discourse forum; and at $50,000 and above the decision goes to VITA holders on Snapshot. Any proposal from the Longevity Dealflow working group goes to Snapshot regardless of size. The constitution writes its top two tiers with a ≤ where the sense requires the opposite bound, so the numeric boundaries read as overlapping, but the escalation it describes is unambiguous: the larger the cheque, the wider the body that has to agree. Day-to-day work runs through specialist working groups (dealflow, tokenomics, awareness, legal and more) staffed by community stewards rather than a single executive team. Turnout at the binding stage is small in absolute terms and lopsided in outcome. The vote.vitadao.eth Snapshot space (https://snapshot.box/#/s:vote.vitadao.eth) has carried 129 proposals against a 1,150,000 VITA quorum; the VDP-163 FOXO3 oligos (https://web.archive.org/web/20250911080521/https://gov.vitadao.com/t/vdp-163-funding-foxo3-oligos-revised/2033) funding vote closed on 16 September 2025 with 17 voters and 6,618,900 VITA cast entirely For, zero Against and zero Abstain, and the January 2025 BIO airdrop vote drew 37. Those are typical: proposals that reach Snapshot have usually been settled on the forum first, so the on-chain vote ratifies rather than decides – a pattern this wiki covers under voter apathy (/wiki/dao-governance/concepts/analysis/voter-apathy) . That space has recorded no new proposal since 9 September 2025.

The Vitality Now Association In December 2024 VitaDAO's community approved VDP-160, establishing Vitality Now (https://web.archive.org/web/20250114000031/https://gov.vitadao.com/t/vdp-160-vitality-now-association-setup-the-new-legal-steward-for-vitadao/1753) , a Swiss association (Verein), as the DAO's legal steward. The binding vote closed on 7 January 2025 with 862,378 VITA For, none Against and 334,534 Abstaining – 1,196,911 cast in total by 37 voters, roughly 4% clear of the space's 1,150,000 quorum, with more than a quarter of the weight cast declining to take a side. The proposal's framing is explicit about the division of labour: decision power stays with VitaDAO's governance mechanisms, and the association executes those decisions inside Swiss and international law. What the association actually holds is the part worth reading closely. Under VDP-160 it becomes the ultimate beneficial owner of all Pods – the semi-autonomous working units such as the Longevity Pod and the Web3 Pod – and it may own or control holding companies that manage projects and IP portfolios. It signs agreements with research institutions, core and strategic contributors, and service providers; it oversees IP acquisition, licensing and enforcement; and it manages contributors' multisignature wallets and payment streams alongside the Pods. Operational detail is delegated to VitaDAO's Guardians, the body responsible for strategic planning and the DAO's budgetary framework. This is the standard shape of a DAO legal wrapper (/wiki/dao-governance/concepts/membership/dao-legal-structures) : a recognised entity that can hold title, sign contracts, and answer to a regulator, sitting beneath a token vote that cannot do any of those things. The trade is equally standard. Everything the association controls – the IP portfolio, the holding companies, the multisigs, the contributor agreements – is governed on-chain only to the extent the association chooses to follow the vote, and members' recourse if it does not is Swiss association law rather than a smart contract.

IP-NFTs and tokenized research The mechanism that distinguishes VitaDAO from an ordinary grants pool is how it holds what it funds. Rather than handing out cash and walking away, VitaDAO captures the intellectual property of funded projects as IP-NFTs (/wiki/desci/ip-nfts) – on-chain assets, built with Molecule (/wiki/desci/ecosystem/molecule) 's tooling, that the community can govern, license, and commercialise. This turns research IP into a treasury asset the DAO co-owns instead of an outcome it merely sponsors. VitaDAO went a step further with VITA-FAST, the first IP-NFT to be fractionalised into an ERC-20 IP token (https://www.vitadao.com/blog/announcing-the-vita-fast-token-sale-for-viktor-korolchuk-lab) . VITA-FAST represents shared ownership of the "Discovering Novel Autophagy Activators" IP-NFT from the Korolchuk Lab at Newcastle University, and its holders directly govern licensing decisions and experiment priorities for that specific research line. This is tokenomics (/wiki/dao-governance/concepts/treasury/dao-tokenomics) in its most literal DeSci form: a tradeable claim minted directly against a real, governed research asset. The second IP token, VITA-RNA, shows what the pattern looks like once a programme is running for years. Its IP-NFT was tokenized in January 2024 and raised $300,000 for ARTAN Bio, whose lead candidate ARTAN-102 is an engineered suppressor tRNA delivered via AAV9 that reads through premature stop codons to restore full-length protein. The programme's milestones are reported through governance: two lead candidates validated in vitro from an initial screen of 15 oligos in October 2024, a first in vivo study in June 2025 reporting no adverse effects and broad biodistribution including the brain, and GMP process development at Lonza through September 2025. The reporting cadence is the point – an IP token gives holders a reason to be told, and a forum thread to be told in.

Funding, Pfizer, and the token-versus-value question In January 2023 VitaDAO closed a $4.1 million round (https://www.vitadao.com/blog/vitadao-closes-4-1m-fundraising-round-with-pfizer-and-shine-capital) whose backers included Pfizer Ventures, Shine Capital, L1 Digital, Beaker DAO, Spaceship DAO, and individuals such as Balaji Srinivasan and Joe Betts-LaCroix – following Pfizer's initial $500k VITA purchase (https://longevity.technology/news/pfizer-invests-500k-in-vitadao-to-accelerate-longevity-rd/) in September 2022 that made it the first pharmaceutical company to hold a governance token and vote on a DAO proposal. That commercialisation raised a familiar structural problem. In April 2023 VitaDAO members voted to create a for-profit company (https://www.coindesk.com/business/2023/04/05/pfizer-backed-vitadao-votes-on-creating-for-profit-company-to-fund-longevity-research) to carry assets through the capital-intensive stages a community treasury can't underwrite – the same token-versus-equity split AthenaDAO (/wiki/desci/ecosystem/athenadao) later reached for with AthenaBIO. A freely-traded governance token's price drifts away from the value of the underlying science, so the DAO governs and sources while separate legal vehicles hold and commercialise the work. The Vitality Now structure above is where that split ended up: an association at the top, Pods beneath it, and holding companies beneath those.

The senior review, and a proposal that never reached a vote Token voting decides whether a grant is popular. It does not decide whether the science is any good, and VitaDAO layers a scored expert gate in front of the vote to close that gap. The clearest published example is VDP-164 (https://web.archive.org/web/20260421081428/https://gov.vitadao.com/t/vdp-164-vitadao-funding-proposal-500k-loan-to-advance-vitarna-through-non-glp-toxicology-toward-2026-ind-submission/2052) , proposed on 16 September 2025: a $500,000 loan to VITARNA/ArtanBIO, recoverable in a later fundraise, to fund GMP manufacturing and non-GLP toxicology in non-human primates ahead of a targeted 2026 IND submission. After the forum poll, four reviewers – two biotech entrepreneurs, one biotech VC and one pharma VC, two of them former scientists – scored the proposal out of 5 across seven categories. The published averages were Team Expertise 3.0, Feasibility & Data 2.5, Commercial Potential & Impact 2.0, Novelty & Market Advantage 3.0, IP Defensibility 3.5, Relevance to Longevity 2.5 and Deal Terms 2.5, for an overall conviction score of 2.3 against an average of 3.7 for past funded projects. Asked whether they would endorse it, one reviewer said only after more robust delivery, efficacy and IP data; one said conditionally, contingent on a rigorous preclinical package and a narrowed initial indication; and one said no, on the grounds that the mechanism had not been shown to address a meaningful driver of aging. Publishing the digest then produced a second argument, about the review rather than the science. On 26 February 2026 a member objected in the thread (https://web.archive.org/web/20260421081428/https://gov.vitadao.com/t/vdp-164-vitadao-funding-proposal-500k-loan-to-advance-vitarna-through-non-glp-toxicology-toward-2026-ind-submission/2052) that only a qualitative summary had been posted, and asked for the reviewer document and the team's written response to be published in full; ARTAN Bio's own chief executive agreed, writing that the community should be able to read the reviews rather than rely on anonymous reviewers whose credentials no one could check. VitaDAO replied on 3 March 2026 that the format matched previous proposals and that it was open to sharing more detail. Nobody posted again. The governance outcome is the part that generalises. VDP-164 has never appeared on VitaDAO's Snapshot space (https://snapshot.box/#/s:vote.vitadao.eth) , whose most recent proposal was created on 9 September 2025 – a week before VDP-164 was posted. The constitution's escalation ladder says a request this size needs the community's approval and a Snapshot vote, and a Longevity Dealflow proposal needs the Snapshot vote whatever its size; in practice the proposal has spent its entire life at the forum-and-review stage, and the binding vote it would have to clear has not been called. A scored expert gate is a real answer to token voting's competence problem, and this is its characteristic failure mode: a low score does not reject a proposal, it strands one, and the record of what happened next lives in a forum thread rather than in a vote anyone can point to. The same tension runs through scoring and review gates (/wiki/dao-governance/concepts/analysis/scoring-and-review-gates) and DAO procurement and RFPs (/wiki/dao-governance/concepts/analysis/dao-procurement-and-rfps) , where a scoring panel decides who is even eligible to be voted on, and through DeSci funding (/wiki/desci/desci-funding) more broadly.

The forum went offline, and took the record with it Every VitaDAO source cited above once pointed at gov.vitadao.com, the DAO's Discourse forum. As of 8 August 2026 that hostname no longer resolves. It is a CNAME to vitadao.hosted-by-discourse.com, and the target carries no address record at either Cloudflare's or Google's public resolver, so a request fails before it reaches a server – the signature of a hosted Discourse instance that has been shut down rather than moved. The Internet Archive's last successful capture of the forum is 7 June 2026; the VDP-164 thread was last captured on 21 April 2026, and its last post is dated 3 March 2026. Nothing on VitaDAO's own site names a replacement, and the site has not noticed. The homepage's structured-data FAQ still answers "How can researchers apply for VitaDAO funding?" by telling them to submit a proposal through the governance forum at gov.vitadao.com (https://www.vitadao.com) – the DAO's front door is routing new research proposals to an address that stopped resolving. What survived is the half of the stack the DAO does not host. The vote.vitadao.eth Snapshot space (https://snapshot.box/#/s:vote.vitadao.eth) still returns all 129 proposals, their choices, their per-option scores and their voter counts to any keyless query, because a Snapshot vote is a signed message on shared infrastructure rather than a page on a rented one. Every figure in the sections above that comes from a ballot – VDP-160's 862,378 For against 334,534 Abstain, VDP-163's 17 voters – was re-read from that hub this week. Every figure that comes from deliberation is now cited through the Internet Archive, which is a fallback and not a source of record: it holds what a crawler happened to reach, not what the forum held. The pattern generalises past VitaDAO, and it cuts in a direction most DAOs have not priced. A DAO that keeps its binding votes on-chain and its reasoning on a hosted forum has split its record across two very different durability guarantees, and the reasoning is the half that goes first. It is also the half that carries the most decisions: under VitaDAO's own ladder everything below $50,000 is settled by stewards, by VitaCore, or by a forum poll, and none of those leave an on-chain trace. So does a proposal that is scored, argued over, and then never put to a vote. A forum is not an archive, and a DAO that treats it as one is one unpaid invoice away from losing the part of its history that explains the votes.

How Caper approaches this The token-versus-value gap VitaDAO patches with a legal wrapper and a separate commercial vehicle is the seam a caper (/wiki/foundations/what-is-a-caper) is built to close. On Caper, contributed capital flows into the caper's own bonding-curve (/wiki/markets/bonding-curve) treasury rather than into a free-floating governance token whose price detaches from the work – value accrues to the treasury itself, and members hold a participation-weighted claim (/wiki/dao-governance/concepts/membership/rage-quit-and-exit-rights) on it. Research spending is authorised the way any spend is: a PAYOUT proposal (/wiki/governance/proposals) that moves a chosen currency and amount from the treasury (/wiki/dao-governance/concepts/treasury/dao-treasury-management) to a lab once members vote it through (/wiki/governance/voting) . Voting weight is stake weighted by participation rather than raw token balance, so the people funding the science keep governance coupled to their exposure – and there is no separate equity vehicle to stand up to keep the token's price from wandering off from the value being built. Caper has no view on which science is worth funding, and nothing in the protocol substitutes for the expert judgement a senior review supplies. What it does change is where a proposal can stall: every proposal a caper's members raise runs to a decision on-ledger, so a funding request either passes or fails on the record rather than lapsing between a review and a vote that is never called. There is also no size threshold below which a spend skips the record: a caper's treasury pays out on an executed proposal, and the proposal, each ranked ballot cast against it, and its execution are all state and events on the caper's own component. The one other way value leaves a caper's treasury is a member taking their exit, and that too is a ledger event rather than a decision recorded somewhere else. It is a narrower record than a forum thread, and the trade is honest: less discussion preserved, none of what is preserved revocable by a lapsed hosting bill.

External links - VitaDAO – official website (https://www.vitadao.com) - VitaDAO on Snapshot (vote.vitadao.eth) (https://snapshot.box/#/s:vote.vitadao.eth) – the live vote record, 129 proposals - VitaDAO whitepaper (PDF) (https://www.vitadao.com/images/vita-labs/VitaDAO_Whitepaper.pdf) - VitaDAO governance forum (https://web.archive.org/web/20260421071625/https://gov.vitadao.com/) – archived; gov.vitadao.com no longer resolves ( category index, 7 June 2026 (https://web.archive.org/web/20260607104504/https://gov.vitadao.com/categories) ) - VitaDAO Governance constitution (https://web.archive.org/web/20260519191733/https://gov.vitadao.com/t/vitadao-governance/787) – archived; the escalation ladder and proposal types - VDP-160 – Vitality Now Association setup (https://web.archive.org/web/20250114000031/https://gov.vitadao.com/t/vdp-160-vitality-now-association-setup-the-new-legal-steward-for-vitadao/1753) – archived - VDP-161 – BIO token airdrop to the VitaDAO community (https://web.archive.org/web/20250114004345/https://gov.vitadao.com/t/vdp-161-bio-token-airdrop-to-vitadao-community/1755) – archived - VDP-164 – $500K VITARNA loan, with the senior-review digest (https://web.archive.org/web/20260421081428/https://gov.vitadao.com/t/vdp-164-vitadao-funding-proposal-500k-loan-to-advance-vitarna-through-non-glp-toxicology-toward-2026-ind-submission/2052) – archived - VitaDAO on X (https://x.com/vitadao)

Type DeSci DAO – longevity research Founded June 2021 (first DeSci DAO) Focus Funding early-stage longevity & aging science Token VITA (governance-only, ERC-20) Governance Snapshot (gasless, shielded); weight = VITA held Ecosystem Bio Protocol (/wiki/desci/ecosystem/bio-xyz) BioDAO IP model IP-NFTs (/wiki/desci/ip-nfts) ( Molecule (/wiki/desci/ecosystem/molecule) tooling); VITA-FAST / VITA-RNA IP tokens Track record 31 projects funded, ~$4.7M deployed, 3 companies spun out Notable backers Pfizer Ventures, Shine Capital, Balaji Srinivasan Chain Ethereum Website vitadao.com (https://www.vitadao.com)

Overview VitaDAO is a community-owned collective that funds and advances early-stage longevity science (https://www.vitadao.com) – the first decentralized science (DeSci) (/wiki/desci/what-is-desci) DAO, launched in June 2021 out of a whitepaper by Tyler Golato and Paul Kohlhaas (https://www.vitadao.com/images/vita-labs/VitaDAO_Whitepaper.pdf) of Molecule (/wiki/desci/ecosystem/molecule) , and since grown into the largest organisation in the field. Its aim is to extend human healthspan by pooling community capital to de-risk translational aging research that traditional grant pipelines and venture funds routinely skip. VitaDAO operates as a BioDAO within the Bio Protocol (/wiki/desci/ecosystem/bio-xyz) ecosystem (the network Molecule grew into), and in August 2024 received a 21 million BIO token allocation (https://gov.vitadao.com/t/vdp-161-bio-token-airdrop-to-vitadao-community/1755) from Bio Protocol's bio/acc rewards program in recognition of its founding role – giving it a stake in governing new BioDAO launches and ecosystem incentives.

Governance and the VITA token $VITA is a governance-only token (https://www.vitadao.com/blog/beginners-guide-to-vita-token) : it confers no dividend and exists to steer the DAO. Voting happens on Snapshot in a gasless, shielded format (https://gov.vitadao.com/t/how-to-vote-on-snapshot/490) – members must hold VITA in an Ethereum wallet, weight scales with the number of tokens held, and results stay hidden until the vote closes so early tallies don't sway later voters. This is textbook token-weighted governance (/wiki/daos/concepts/voting/voting-and-delegation) , and it inherits token-weighted governance's core tension: influence tracks holdings, not contribution. Funding decisions escalate by size. Per the VitaDAO constitution (https://gov.vitadao.com/t/vitadao-governance/787) , a request up to ~$2,500 needs sign-off from two working-group representatives; up to ~$10,000 needs a majority of working-group stewards; up to ~$50,000 goes to a public governance-forum poll; and anything larger requires that poll plus a full Snapshot vote. Day-to-day work runs through specialist working groups (dealflow, tokenomics, awareness, legal and more) staffed by community stewards rather than a single executive team.

IP-NFTs and tokenized research The mechanism that distinguishes VitaDAO from an ordinary grants pool is how it holds what it funds. Rather than handing out cash and walking away, VitaDAO captures the intellectual property of funded projects as IP-NFTs (/wiki/desci/ip-nfts) – on-chain assets, built with Molecule (/wiki/desci/ecosystem/molecule) 's tooling, that the community can govern, license, and commercialise. This turns research IP into a treasury asset the DAO co-owns instead of an outcome it merely sponsors. VitaDAO went a step further with VITA-FAST, the first IP-NFT to be fractionalised into an ERC-20 IP token (https://www.vitadao.com/blog/announcing-the-vita-fast-token-sale-for-viktor-korolchuk-lab) . VITA-FAST represents shared ownership of the "Discovering Novel Autophagy Activators" IP-NFT from the Korolchuk Lab at Newcastle University, and its holders directly govern licensing decisions and experiment priorities for that specific research line. A later IP token, VITA-RNA, applied the same pattern to another project. This is tokenomics (/wiki/daos/concepts/treasury/dao-tokenomics) in its most literal DeSci form: a tradeable claim minted directly against a real, governed research asset.

Funding, Pfizer, and the token-versus-value question In January 2023 VitaDAO closed a $4.1 million round (https://www.vitadao.com/blog/vitadao-closes-4-1m-fundraising-round-with-pfizer-and-shine-capital) whose backers included Pfizer Ventures, Shine Capital, L1 Digital, Beaker DAO, Spaceship DAO, and individuals such as Balaji Srinivasan and Joe Betts-LaCroix – following Pfizer's initial $500k VITA purchase (https://longevity.technology/news/pfizer-invests-500k-in-vitadao-to-accelerate-longevity-rd/) in September 2022 that made it the first pharmaceutical company to hold a governance token and vote on a DAO proposal. To date the DAO has funded 31 projects and deployed roughly $4.7M (https://www.vitadao.com) across the drug-development pipeline, generating IP transactions and three spun-out companies. That commercialisation raised a familiar structural problem. In April 2023 VitaDAO members voted to create a for-profit company (https://www.coindesk.com/business/2023/04/05/pfizer-backed-vitadao-votes-on-creating-for-profit-company-to-fund-longevity-research) to carry assets through the capital-intensive stages a community treasury can't underwrite – the same token-versus-equity split AthenaDAO (/wiki/desci/ecosystem/athenadao) later reached for with AthenaBIO. A freely-traded governance token's price drifts away from the value of the underlying science, so the DAO governs and sources while a separate legal vehicle holds and commercialises the work.

How Caper approaches this The token-versus-value gap VitaDAO patches with a for-profit spinout is the seam a caper (/wiki/foundations/what-is-a-caper) is built to close. On Caper, contributed capital flows into the caper's own bonding-curve (/wiki/markets/bonding-curve) treasury rather than into a free-floating governance token whose price detaches from the work – value accrues to the treasury itself, and members hold a participation-weighted claim (/wiki/daos/concepts/membership/rage-quit-and-exit-rights) on it. Research spending is authorised the way any spend is: a PAYOUT proposal (/wiki/governance/proposals) that moves a chosen currency and amount from the treasury (/wiki/daos/concepts/treasury/dao-treasury-management) to a lab once members vote it through (/wiki/governance/voting) . Voting weight is stake weighted by participation rather than raw token balance, so the people funding the science keep governance coupled to their exposure – and there is no separate equity vehicle to stand up to keep the token's price from wandering off from the value being built.

External links - VitaDAO – official website (https://www.vitadao.com) - VitaDAO governance forum (https://gov.vitadao.com/) - VitaDAO whitepaper (PDF) (https://www.vitadao.com/images/vita-labs/VitaDAO_Whitepaper.pdf) - VitaDAO on X (https://x.com/vitadao)

Type DeSci DAO – longevity research Founded June 2021 (first DeSci DAO) Focus Funding early-stage longevity & aging science Token VITA (governance-only, ERC-20) Governance Snapshot (gasless, shielded); weight = VITA held. 129 proposals; most recent created 9 Sep 2025 Legal steward Vitality Now, a Swiss association (Verein) – VDP-160 (https://gov.vitadao.com/t/vdp-160-vitality-now-association-setup-the-new-legal-steward-for-vitadao/1753) , Dec 2024 Ecosystem Bio Protocol (/wiki/desci/ecosystem/bio-xyz) BioDAO IP model IP-NFTs (/wiki/desci/ip-nfts) ( Molecule (/wiki/desci/ecosystem/molecule) tooling); VITA-FAST / VITA-RNA IP tokens Track record 31 projects funded, ~$4.7M deployed, 8 IP tokens generated, 3 companies spun out Notable backers Pfizer Ventures, Shine Capital, Balaji Srinivasan Chain Ethereum Website vitadao.com (https://www.vitadao.com)

Overview VitaDAO is a community-owned collective that funds and advances early-stage longevity science (https://www.vitadao.com) – the first decentralized science (DeSci) (/wiki/desci/what-is-desci) DAO, launched in June 2021 out of a whitepaper by Tyler Golato and Paul Kohlhaas (https://www.vitadao.com/images/vita-labs/VitaDAO_Whitepaper.pdf) of Molecule (/wiki/desci/ecosystem/molecule) , and since grown into the largest organisation in the field. Its aim is to extend human healthspan by pooling community capital to de-risk translational aging research that traditional grant pipelines and venture funds routinely skip. VitaDAO operates as a BioDAO within the Bio Protocol (/wiki/desci/ecosystem/bio-xyz) ecosystem (the network Molecule grew into), and in August 2024 received a 21 million BIO token allocation (https://gov.vitadao.com/t/vdp-161-bio-token-airdrop-to-vitadao-community/1755) from Bio Protocol's bio/acc rewards program in recognition of its founding role – giving it a stake in governing new BioDAO launches and ecosystem incentives. The DAO reports 31 projects funded and roughly $4.7M deployed (https://www.vitadao.com) , split across 3 target-discovery, 18 drug-discovery, 3 preclinical and 3 clinical drug-development projects, with 8 IP tokens generated and 3 companies founded.

Governance and the VITA token $VITA is a governance-only token (https://www.vitadao.com/blog/beginners-guide-to-vita-token) : it confers no dividend and exists to steer the DAO. Voting happens on Snapshot in a gasless, shielded format (https://gov.vitadao.com/t/how-to-vote-on-snapshot/490) – members must hold VITA in an Ethereum wallet, weight scales with the number of tokens held, and results stay hidden until the vote closes so early tallies don't sway later voters. This is textbook token-weighted governance (/wiki/dao-governance/concepts/voting/voting-and-delegation) , and it inherits token-weighted governance's core tension: influence tracks holdings, not contribution. Funding decisions escalate by size. Per the VitaDAO constitution (https://gov.vitadao.com/t/vitadao-governance/787) , a request up to ~$2,500 needs sign-off from two working-group representatives; up to ~$10,000 needs a majority of working-group stewards; up to ~$50,000 goes to a public governance-forum poll; and anything larger requires that poll plus a full Snapshot vote. Day-to-day work runs through specialist working groups (dealflow, tokenomics, awareness, legal and more) staffed by community stewards rather than a single executive team. Turnout at the binding stage is small in absolute terms and lopsided in outcome. The vote.vitadao.eth Snapshot space (https://snapshot.box/#/s:vote.vitadao.eth) has carried 129 proposals; the VDP-163 FOXO3 oligos (https://gov.vitadao.com/t/vdp-163-funding-foxo3-oligos-revised/2033) funding vote closed on 16 September 2025 with 17 voters and 6,618,900 VITA cast entirely For, zero Against and zero Abstain, and the January 2025 BIO airdrop vote drew 37. Those are typical: proposals that reach Snapshot have usually been settled on the forum first, so the on-chain vote ratifies rather than decides – a pattern this wiki covers under voter apathy (/wiki/dao-governance/concepts/analysis/voter-apathy) . That space has recorded no new proposal since 9 September 2025.

The Vitality Now Association In December 2024 VitaDAO's community approved VDP-160, establishing Vitality Now (https://gov.vitadao.com/t/vdp-160-vitality-now-association-setup-the-new-legal-steward-for-vitadao/1753) , a Swiss association (Verein), as the DAO's legal steward. The forum poll closed 10 Agree, 0 Revisions Requested, 0 Disagree. The proposal's framing is explicit about the division of labour: decision power stays with VitaDAO's governance mechanisms, and the association executes those decisions inside Swiss and international law. What the association actually holds is the part worth reading closely. Under VDP-160 it becomes the ultimate beneficial owner of all Pods – the semi-autonomous working units such as the Longevity Pod and the Web3 Pod – and it may own or control holding companies that manage projects and IP portfolios. It signs agreements with research institutions, core and strategic contributors, and service providers; it oversees IP acquisition, licensing and enforcement; and it manages contributors' multisignature wallets and payment streams alongside the Pods. Operational detail is delegated to VitaDAO's Guardians, the body responsible for strategic planning and the DAO's budgetary framework. This is the standard shape of a DAO legal wrapper (/wiki/dao-governance/concepts/membership/dao-legal-structures) : a recognised entity that can hold title, sign contracts, and answer to a regulator, sitting beneath a token vote that cannot do any of those things. The trade is equally standard. Everything the association controls – the IP portfolio, the holding companies, the multisigs, the contributor agreements – is governed on-chain only to the extent the association chooses to follow the vote, and members' recourse if it does not is Swiss association law rather than a smart contract.

IP-NFTs and tokenized research The mechanism that distinguishes VitaDAO from an ordinary grants pool is how it holds what it funds. Rather than handing out cash and walking away, VitaDAO captures the intellectual property of funded projects as IP-NFTs (/wiki/desci/ip-nfts) – on-chain assets, built with Molecule (/wiki/desci/ecosystem/molecule) 's tooling, that the community can govern, license, and commercialise. This turns research IP into a treasury asset the DAO co-owns instead of an outcome it merely sponsors. VitaDAO went a step further with VITA-FAST, the first IP-NFT to be fractionalised into an ERC-20 IP token (https://www.vitadao.com/blog/announcing-the-vita-fast-token-sale-for-viktor-korolchuk-lab) . VITA-FAST represents shared ownership of the "Discovering Novel Autophagy Activators" IP-NFT from the Korolchuk Lab at Newcastle University, and its holders directly govern licensing decisions and experiment priorities for that specific research line. This is tokenomics (/wiki/dao-governance/concepts/treasury/dao-tokenomics) in its most literal DeSci form: a tradeable claim minted directly against a real, governed research asset. The second IP token, VITA-RNA, shows what the pattern looks like once a programme is running for years. Its IP-NFT was tokenized in January 2024 and raised $300,000 for ARTAN Bio, whose lead candidate ARTAN-102 is an engineered suppressor tRNA delivered via AAV9 that reads through premature stop codons to restore full-length protein. The programme's milestones are reported through governance: two lead candidates validated in vitro from an initial screen of 15 oligos in October 2024, a first in vivo study in June 2025 reporting no adverse effects and broad biodistribution including the brain, and GMP process development at Lonza through September 2025. The reporting cadence is the point – an IP token gives holders a reason to be told, and a forum thread to be told in.

Funding, Pfizer, and the token-versus-value question In January 2023 VitaDAO closed a $4.1 million round (https://www.vitadao.com/blog/vitadao-closes-4-1m-fundraising-round-with-pfizer-and-shine-capital) whose backers included Pfizer Ventures, Shine Capital, L1 Digital, Beaker DAO, Spaceship DAO, and individuals such as Balaji Srinivasan and Joe Betts-LaCroix – following Pfizer's initial $500k VITA purchase (https://longevity.technology/news/pfizer-invests-500k-in-vitadao-to-accelerate-longevity-rd/) in September 2022 that made it the first pharmaceutical company to hold a governance token and vote on a DAO proposal. That commercialisation raised a familiar structural problem. In April 2023 VitaDAO members voted to create a for-profit company (https://www.coindesk.com/business/2023/04/05/pfizer-backed-vitadao-votes-on-creating-for-profit-company-to-fund-longevity-research) to carry assets through the capital-intensive stages a community treasury can't underwrite – the same token-versus-equity split AthenaDAO (/wiki/desci/ecosystem/athenadao) later reached for with AthenaBIO. A freely-traded governance token's price drifts away from the value of the underlying science, so the DAO governs and sources while separate legal vehicles hold and commercialise the work. The Vitality Now structure above is where that split ended up: an association at the top, Pods beneath it, and holding companies beneath those.

The senior review, and a proposal that never reached a vote Token voting decides whether a grant is popular. It does not decide whether the science is any good, and VitaDAO layers a scored expert gate in front of the vote to close that gap. The clearest published example is VDP-164 (https://gov.vitadao.com/t/vdp-164-vitadao-funding-proposal-500k-loan-to-advance-vitarna-through-non-glp-toxicology-toward-2026-ind-submission/2052) , proposed on 16 September 2025: a $500,000 loan to VITARNA/ArtanBIO, recoverable in a later fundraise, to fund GMP manufacturing and non-GLP toxicology in non-human primates ahead of a targeted 2026 IND submission. After the forum poll, four reviewers – two biotech entrepreneurs, one biotech VC and one pharma VC, two of them former scientists – scored the proposal out of 5 across seven categories. The published averages were Team Expertise 3.0, Feasibility & Data 2.5, Commercial Potential & Impact 2.0, Novelty & Market Advantage 3.0, IP Defensibility 3.5, Relevance to Longevity 2.5 and Deal Terms 2.5, for an overall conviction score of 2.3 against an average of 3.7 for past funded projects. Asked whether they would endorse it, one reviewer said only after more robust delivery, efficacy and IP data; one said conditionally, contingent on a rigorous preclinical package and a narrowed initial indication; and one said no, on the grounds that the mechanism had not been shown to address a meaningful driver of aging. Publishing the digest then produced a second argument, about the review rather than the science. On 26 February 2026 a member objected in the thread (https://gov.vitadao.com/t/vdp-164-vitadao-funding-proposal-500k-loan-to-advance-vitarna-through-non-glp-toxicology-toward-2026-ind-submission/2052) that only a qualitative summary had been posted, and asked for the reviewer document and the team's written response to be published in full; ARTAN Bio's own chief executive agreed, writing that the community should be able to read the reviews rather than rely on anonymous reviewers whose credentials no one could check. VitaDAO replied on 3 March 2026 that the format matched previous proposals and that it was open to sharing more detail. The governance outcome is the part that generalises. VDP-164 has never appeared on VitaDAO's Snapshot space (https://snapshot.box/#/s:vote.vitadao.eth) , whose most recent proposal was created on 9 September 2025 – a week before VDP-164 was posted. The constitution's escalation ladder says a request this size needs a forum poll and a Snapshot vote; in practice the proposal has spent its entire life at the forum-and-review stage, and the binding vote it would have to clear has not been called. A scored expert gate is a real answer to token voting's competence problem, and this is its characteristic failure mode: a low score does not reject a proposal, it strands one, and the record of what happened next lives in a forum thread rather than in a vote anyone can point to. The same tension runs through DAO procurement and RFPs (/wiki/dao-governance/concepts/analysis/dao-procurement-and-rfps) , where a scoring panel decides who is even eligible to be voted on, and through DeSci funding (/wiki/desci/desci-funding) more broadly.

How Caper approaches this The token-versus-value gap VitaDAO patches with a legal wrapper and a separate commercial vehicle is the seam a caper (/wiki/foundations/what-is-a-caper) is built to close. On Caper, contributed capital flows into the caper's own bonding-curve (/wiki/markets/bonding-curve) treasury rather than into a free-floating governance token whose price detaches from the work – value accrues to the treasury itself, and members hold a participation-weighted claim (/wiki/dao-governance/concepts/membership/rage-quit-and-exit-rights) on it. Research spending is authorised the way any spend is: a PAYOUT proposal (/wiki/governance/proposals) that moves a chosen currency and amount from the treasury (/wiki/dao-governance/concepts/treasury/dao-treasury-management) to a lab once members vote it through (/wiki/governance/voting) . Voting weight is stake weighted by participation rather than raw token balance, so the people funding the science keep governance coupled to their exposure – and there is no separate equity vehicle to stand up to keep the token's price from wandering off from the value being built. Caper has no view on which science is worth funding, and nothing in the protocol substitutes for the expert judgement a senior review supplies. What it does change is where a proposal can stall: every proposal a caper's members raise runs to a decision on-ledger, so a funding request either passes or fails on the record rather than lapsing between a review and a vote that is never called.

External links - VitaDAO – official website (https://www.vitadao.com) - VitaDAO governance forum (https://gov.vitadao.com/) - VitaDAO on Snapshot (vote.vitadao.eth) (https://snapshot.box/#/s:vote.vitadao.eth) - VitaDAO whitepaper (PDF) (https://www.vitadao.com/images/vita-labs/VitaDAO_Whitepaper.pdf) - VDP-160 – Vitality Now Association setup (https://gov.vitadao.com/t/vdp-160-vitality-now-association-setup-the-new-legal-steward-for-vitadao/1753) - VDP-164 – $500K VITARNA loan, with the senior-review digest (https://gov.vitadao.com/t/vdp-164-vitadao-funding-proposal-500k-loan-to-advance-vitarna-through-non-glp-toxicology-toward-2026-ind-submission/2052) - VitaDAO on X (https://x.com/vitadao)

Governance and the VITA token …weighted governance (/wiki/daos/concepts/voting/voting-and-delegation) , and it inhe… than a single executive team.

IP-NFTs and tokenized research…This is tokenomics (/wiki/daos/concepts/treasury/dao-tokenomics) in its most l…real, governed research asset.

How Caper approaches this The …tion-weighted claim (/wiki/daos/concepts/membership/rage-quit-and-exit-rights) on… from the treasury (/wiki/daos/concepts/treasury/dao-treasury-management) to a…ff from the value being built.

Type DeSci DAO Founded July 2021 Focus Longevity Research Projects Funded 31 Capital Deployed $4.7M Companies Founded 3 IP Transactions 8 Chain Ethereum Website vitadao.com (https://www.vitadao.com)

Overview VitaDAO is a community-owned collective dedicated to funding and advancing early-stage longevity science research (https://www.vitadao.com) . It was the first DeSci DAO, initiated in July 2021, and has since become the largest in the ecosystem. The organization aims to extend human healthspan and lifespan through accelerated research, open collaboration, and innovative funding structures. VitaDAO received a landmark $4.1 million investment from Pfizer Ventures in December 2022 (https://www.bio.xyz) , marking one of the first major pharmaceutical industry investments in a decentralized science organization. It operates as a BioDAO within the Bio Protocol (/wiki/desci/ecosystem/bio-xyz) ecosystem, and in August 2024 received a 21 million BIO token allocation (https://gov.vitadao.com/t/vdp-161-bio-token-airdrop-to-vitadao-community/1755) from Bio Protocol’s bio/acc rewards program in recognition of its pioneering role — giving it governance rights over new BioDAO launches and ecosystem incentives.

Research Portfolio VitaDAO has funded 31 projects (https://www.vitadao.com) across the drug development pipeline: 3 target discovery projects, 18 drug discovery projects, 3 preclinical drug development projects, and 3 clinical drug development projects. This has generated 8 intellectual property transactions and led to the founding of 3 companies, with a total project fully diluted valuation of $60 million. The DAO combines human expertise with AI agents — including AubrAI (longevity research specialist), Longevist AI for literature analysis, and a Biohacker Agent for compound formulation — to accelerate discovery in aging research.

External Links - VitaDAO — Official Website (https://www.vitadao.com) - VitaDAO Discord (https://discord.gg/vitadao) - VitaDAO on X (https://x.com/vitadao)

Type DeSci DAO – longevity research Founded June 2021 (first DeSci DAO) Focus Funding early-stage longevity & aging science Token VITA (governance-only, ERC-20) Governance Snapshot (gasless, shielded); weight = VITA held Ecosystem Bio Protocol (/wiki/desci/ecosystem/bio-xyz) BioDAO IP model IP-NFTs (/wiki/desci/ip-nfts) ( Molecule (/wiki/desci/ecosystem/molecule) tooling); VITA-FAST / VITA-RNA IP tokens Track record 31 projects funded, ~$4.7M deployed, 3 companies spun out Notable backers Pfizer Ventures, Shine Capital, Balaji Srinivasan Chain Ethereum Website vitadao.com (https://www.vitadao.com)

Overview VitaDAO is a community-owned collective that funds and advances early-stage longevity science (https://www.vitadao.com) – the first decentralized science (DeSci) (/wiki/desci/what-is-desci) DAO, launched in June 2021 out of a whitepaper by Tyler Golato and Paul Kohlhaas (https://www.vitadao.com/images/vita-labs/VitaDAO_Whitepaper.pdf) of Molecule (/wiki/desci/ecosystem/molecule) , and since grown into the largest organisation in the field. Its aim is to extend human healthspan by pooling community capital to de-risk translational aging research that traditional grant pipelines and venture funds routinely skip. VitaDAO operates as a BioDAO within the Bio Protocol (/wiki/desci/ecosystem/bio-xyz) ecosystem (the network Molecule grew into), and in August 2024 received a 21 million BIO token allocation (https://gov.vitadao.com/t/vdp-161-bio-token-airdrop-to-vitadao-community/1755) from Bio Protocol's bio/acc rewards program in recognition of its founding role – giving it a stake in governing new BioDAO launches and ecosystem incentives.

Governance and the VITA token $VITA is a governance-only token (https://www.vitadao.com/blog/beginners-guide-to-vita-token) : it confers no dividend and exists to steer the DAO. Voting happens on Snapshot in a gasless, shielded format (https://gov.vitadao.com/t/how-to-vote-on-snapshot/490) – members must hold VITA in an Ethereum wallet, weight scales with the number of tokens held, and results stay hidden until the vote closes so early tallies don't sway later voters. This is textbook token-weighted governance (/wiki/dao/concepts/voting-and-delegation) , and it inherits token-weighted governance's core tension: influence tracks holdings, not contribution. Funding decisions escalate by size. Per the VitaDAO constitution (https://gov.vitadao.com/t/vitadao-governance/787) , a request up to ~$2,500 needs sign-off from two working-group representatives; up to ~$10,000 needs a majority of working-group stewards; up to ~$50,000 goes to a public governance-forum poll; and anything larger requires that poll plus a full Snapshot vote. Day-to-day work runs through specialist working groups (dealflow, tokenomics, awareness, legal and more) staffed by community stewards rather than a single executive team.

IP-NFTs and tokenized research The mechanism that distinguishes VitaDAO from an ordinary grants pool is how it holds what it funds. Rather than handing out cash and walking away, VitaDAO captures the intellectual property of funded projects as IP-NFTs (/wiki/desci/ip-nfts) – on-chain assets, built with Molecule (/wiki/desci/ecosystem/molecule) 's tooling, that the community can govern, license, and commercialise. This turns research IP into a treasury asset the DAO co-owns instead of an outcome it merely sponsors. VitaDAO went a step further with VITA-FAST, the first IP-NFT to be fractionalised into an ERC-20 IP token (https://www.vitadao.com/blog/announcing-the-vita-fast-token-sale-for-viktor-korolchuk-lab) . VITA-FAST represents shared ownership of the "Discovering Novel Autophagy Activators" IP-NFT from the Korolchuk Lab at Newcastle University, and its holders directly govern licensing decisions and experiment priorities for that specific research line. A later IP token, VITA-RNA, applied the same pattern to another project. This is tokenomics (/wiki/dao/concepts/dao-tokenomics) in its most literal DeSci form: a tradeable claim minted directly against a real, governed research asset.

Funding, Pfizer, and the token-versus-value question In January 2023 VitaDAO closed a $4.1 million round (https://www.vitadao.com/blog/vitadao-closes-4-1m-fundraising-round-with-pfizer-and-shine-capital) whose backers included Pfizer Ventures, Shine Capital, L1 Digital, Beaker DAO, Spaceship DAO, and individuals such as Balaji Srinivasan and Joe Betts-LaCroix – following Pfizer's initial $500k VITA purchase (https://longevity.technology/news/pfizer-invests-500k-in-vitadao-to-accelerate-longevity-rd/) in September 2022 that made it the first pharmaceutical company to hold a governance token and vote on a DAO proposal. To date the DAO has funded 31 projects and deployed roughly $4.7M (https://www.vitadao.com) across the drug-development pipeline, generating IP transactions and three spun-out companies. That commercialisation raised a familiar structural problem. In April 2023 VitaDAO members voted to create a for-profit company (https://www.coindesk.com/business/2023/04/05/pfizer-backed-vitadao-votes-on-creating-for-profit-company-to-fund-longevity-research) to carry assets through the capital-intensive stages a community treasury can't underwrite – the same token-versus-equity split AthenaDAO (/wiki/desci/ecosystem/athenadao) later reached for with AthenaBIO. A freely-traded governance token's price drifts away from the value of the underlying science, so the DAO governs and sources while a separate legal vehicle holds and commercialises the work.

How Caper approaches this The token-versus-value gap VitaDAO patches with a for-profit spinout is the seam a caper (/wiki/foundations/what-is-a-caper) is built to close. On Caper, contributed capital flows into the caper's own bonding-curve (/wiki/markets/bonding-curve) treasury rather than into a free-floating governance token whose price detaches from the work – value accrues to the treasury itself, and members hold a participation-weighted claim (/wiki/dao/concepts/rage-quit-and-exit-rights) on it. Research spending is authorised the way any spend is: a PAYOUT proposal (/wiki/governance/proposals) that moves a chosen currency and amount from the treasury (/wiki/dao/concepts/dao-treasury-management) to a lab once members vote it through (/wiki/governance/voting) . Voting weight is stake weighted by participation rather than raw token balance, so the people funding the science keep governance coupled to their exposure – and there is no separate equity vehicle to stand up to keep the token's price from wandering off from the value being built.

External links - VitaDAO – official website (https://www.vitadao.com) - VitaDAO governance forum (https://gov.vitadao.com/) - VitaDAO whitepaper (PDF) (https://www.vitadao.com/images/vita-labs/VitaDAO_Whitepaper.pdf) - VitaDAO on X (https://x.com/vitadao)

Overview VitaDAO is a communi…BIO token allocation (https://wwwgov.vitadao.com/blog/vitadao-receives-21m-bio-tokens-for-pioneering-descit/vdp-161-bio-token-airdrop-to-vitadao-community/1755) from Bio Protocol’s bio/acc…ches and ecosystem incentives.

External Links - VitaDAO — Of…taDAO on X (https://x.com/vita_dao)

Type DeSci DAO Founded July 2021 Focus Longevity Research Projects Funded 31 Capital Deployed $4.7M Companies Founded 3 IP Transactions 8 Chain Ethereum Website vitadao.com (https://www.vitadao.com)

Overview VitaDAO is a community-owned collective dedicated to funding and advancing early-stage longevity science research (https://www.vitadao.com) . It was the first DeSci DAO, initiated in July 2021, and has since become the largest in the ecosystem. The organization aims to extend human healthspan and lifespan through accelerated research, open collaboration, and innovative funding structures. VitaDAO received a landmark $4.1 million investment from Pfizer Ventures in December 2022 (https://www.bio.xyz) , marking one of the first major pharmaceutical industry investments in a decentralized science organization. It operates as a BioDAO within the Bio Protocol (/wiki/desci/ecosystem/bio-xyz) ecosystem, and in August 2024 received a 21 million BIO token allocation (https://www.vitadao.com/blog/vitadao-receives-21m-bio-tokens-for-pioneering-desci) from Bio Protocol’s bio/acc rewards program in recognition of its pioneering role — giving it governance rights over new BioDAO launches and ecosystem incentives.

Research Portfolio VitaDAO has funded 31 projects (https://www.vitadao.com) across the drug development pipeline: 3 target discovery projects, 18 drug discovery projects, 3 preclinical drug development projects, and 3 clinical drug development projects. This has generated 8 intellectual property transactions and led to the founding of 3 companies, with a total project fully diluted valuation of $60 million. The DAO combines human expertise with AI agents — including AubrAI (longevity research specialist), Longevist AI for literature analysis, and a Biohacker Agent for compound formulation — to accelerate discovery in aging research.

External Links - VitaDAO — Official Website (https://www.vitadao.com) - VitaDAO Discord (https://discord.gg/vitadao) - VitaDAO on X (https://x.com/vita_dao)